---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-038235"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T07:01:42.582774+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cibus Q3 2023 net loss $34.5M; cash runway only into early Q1 2024

## Summary
- Net loss of $34.5M ($1.59 per share) vs. $6.0M a year ago; R&D spend jumped to $17.5M.
- Cash and equivalents $31.9M; company warns cash covers only planned ops into Q1 2024.
- Strategic realignment & cost cuts initiated to focus on late-stage traits; no revenue reported.
- Completed field trials for PSR canola, HT1/HT3 rice; returned edited germplasm to 2 of 10 customers.
- UK field trials for PSR in WOSR started; EU proposed gene-editing rules seen as favorable.

## SEC filing metadata
- accession: 0001628280-23-038235
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000162828023038235/0001628280-23-038235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000162828023038235/cbus-20231109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-038235
- JSON: https://secwatch.observer/filing/0001628280-23-038235.json
- Plain text: https://secwatch.observer/filing/0001628280-23-038235.txt

## Key facts
- Earnings Releases
  Cibus, Inc. reported financial results for the three months ended September 30, 2023.
  - Period: the three months ended September 30, 2023
  - Result: reported results
  source text: On November 9, 2023, Cibus, Inc. (the “Company”) announced its financial results for the three months ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1705843/000162828023038235/0001628280-23-038235-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.